DJIA 17,131.86 47.37 0.28%
NASDAQ 4,838.64 8.17 0.17%
S&P 500 2,017.46 2.57 0.13%
market minute promo

GlaxoSmithKline (NYSE: GSK)

40.38 0.16 (0.40%)

REAL-TIME: Last trade at

Extended Hours: $40.40 $0.02 (0.05%)
Quote as of (NYSE)

company name or ticker

Recent Quotes

GSK $40.38 0.40%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.00
Previous Close $40.22
Daily Range $39.90 - $40.59
52-Week Range $37.24 - $49.08
Market Cap $87.7B
P/E Ratio 13.82
Dividend (Yield) $2.31 (6.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,985,085
Average Daily Volume 3,495,463
Current FY EPS $2.39




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary

Would an Ebola Vaccine Move Regeneron Pharmaceuticals' Bottom Line?

Regeneron Pharmaceuticals has won a BARDA agreement to develop a potential vaccine for the Ebola virus. How big of a deal is it for Regeneron investors today?

MannKind: Weekly Data Updates

Buy-Rated Dividend Stocks In The Top 3: STWD, GSK, T

Bristol-Myers to Pay $14M to Settle China Bribe Charges

9 Sector-Leading Dividend Dogs Average 20% Yields As Of September 30

Gilead's Letairis Gets FDA Nod in Combination with Adcirca

3 Drugs Stocks Moving The Industry Upward

Mirna Therapeutics: A Healthy IPO To Start The Week

Clinton Proposals Could Spell Trouble for These 3 Drugmakers

An empowered Medicare program could pressure sales for GlaxoSmithKline, Merck, and Celgene.

3 Stocks We're Ready to Sell

When the market gets choppy, it can be a good time take a hard look at your portfolio.

See More GSK News...

GSK's Top Competitors

GSK $40.38 (0.40%)
Current stock: GSK
JNJ $95.99 (0.65%)
Current stock: JNJ
PFE $33.22 (-0.06%)
Current stock: PFE
RHHBY $33.00 (0.43%)
Current stock: RHHBY